Skip to content
Screener

Accounts Payable at other companies

HRO
HarrowHROW
$26.27M+12.2%
XER
Xeris Biopharma Holdings, Inc.XERS
$9.34M-1.3%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$73.83M+35.3%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$13.96M-11.9%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$4.49M+13.5%
Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
$850K+5,100%

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$1.22B+167%
Enterprise value$1.23B+167%
P/S14.1×+6.2×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%
Net margin-9.5%-2.7pp
FCF margin17.1%

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:17 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001437749-26-017064
Line itemMarch 31, 2026December 31, 2025
Total assets$97,710$92,114
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$13,485$10,976
Short-term debt, net of debt discount11,8088,789
Accrued Medicaid rebates11,1409,317
Accrued liabilities7,7469,408
Total current liabilities44,17938,490

Document

FAQ

What is Eton Pharmaceuticals, Inc.'s accounts payable?
Eton Pharmaceuticals, Inc. (ETON) reported accounts payable of $13.49M in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s accounts payable changed year-over-year?
Eton Pharmaceuticals, Inc.'s accounts payable increased by 176.8% year-over-year, from $4.87M to $13.49M.
What is the long-term trend for Eton Pharmaceuticals, Inc.'s accounts payable?
Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s accounts payable has grown at a 36.2% compound annual growth rate (CAGR), from $2.34M to $10.98M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.

Ask your AI about Eton Pharmaceuticals, Inc.'s accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude